Found: 32
Select item for more details and to access through your institution.
Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0091-4
- By:
- Publication type:
- Article
Histomorphological responses after therapy with pegylated interferon a-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV).
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0090-5
- By:
- Publication type:
- Article
Extraordinary clinical benefit to sequential treatment with targeted therapy and immunotherapy of a BRAF V600E and PD-L1 positive metastatic lung adenocarcinoma.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0089-y
- By:
- Publication type:
- Article
Incorporation of functional elements enhances the antitumor capacity of CAR T cells.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0088-z
- By:
- Publication type:
- Article
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0086-1
- By:
- Publication type:
- Article
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0087-0
- By:
- Publication type:
- Article
Complete biochemical response after pulmonary metastasectomy in prostate adenocarcinoma.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0085-2
- By:
- Publication type:
- Article
Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0082-5
- By:
- Publication type:
- Article
Pivotal regulators of tissue homeostasis and cancer: macrophages.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0083-4
- By:
- Publication type:
- Article
Microfluidic device for primary tumor spheroid isolation.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0084-3
- By:
- Publication type:
- Article
Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0080-7
- By:
- Publication type:
- Article
Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0081-6
- By:
- Publication type:
- Article
PTEN is a negative regulator of mitotic checkpoint complex during the cell cycle.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0079-0
- By:
- Publication type:
- Article
Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0078-1
- By:
- Publication type:
- Article
The role of cullin4B in human cancers.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0077-2
- By:
- Publication type:
- Article
Clinical implications of c-maf expression in plasma cells from patients with multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0076-3
- By:
- Publication type:
- Article
In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0075-4
- By:
- Publication type:
- Article
Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0074-5
- By:
- Publication type:
- Article
Cyclosporine is a potential curative treatment option for advanced thymoma.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0073-6
- By:
- Publication type:
- Article
The development of bispecific antibodies and their applications in tumor immune escape.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0072-7
- By:
- Publication type:
- Article
Metastatic squamous cell carcinoma of colon from esophageal cancer.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0070-9
- By:
- Publication type:
- Article
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0071-8
- By:
- Publication type:
- Article
Acquired factor VIII deficiency: two case reports and a review of literature.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0066-5
- By:
- Publication type:
- Article
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0067-4
- By:
- Publication type:
- Article
A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0065-6
- By:
- Publication type:
- Article
Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0064-7
- By:
- Publication type:
- Article
Molecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI.H) metastatic endometrial cancer.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-016-0061-2
- By:
- Publication type:
- Article
Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-016-0062-1
- By:
- Publication type:
- Article